Tempus Wealth Planning’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $842K | Buy |
4,537
+1,650
| +57% | +$306K | 0.21% | 122 |
|
|
2025
Q1 | $605K | Sell |
2,887
-199
| -6% | -$41.7K | 0.18% | 128 |
|
|
2024
Q4 | $548K | Buy |
3,086
+68
| +2% | +$12.1K | 0.17% | 133 |
|
|
2024
Q3 | $596K | Buy |
3,018
+151
| +5% | +$29.8K | 0.22% | 111 |
|
|
2024
Q2 | $492K | Buy |
2,867
+299
| +12% | +$51.3K | 0.21% | 112 |
|
|
2024
Q1 | $468K | Buy |
2,568
+251
| +11% | +$45.7K | 0.21% | 116 |
|
|
2023
Q4 | $359K | Hold |
2,317
| – | – | 0.16% | 134 |
|
|
2023
Q3 | $345K | Sell |
2,317
-2,333
| -50% | -$348K | 0.17% | 113 |
|
|
2023
Q2 | $626K | Sell |
4,650
-175
| -4% | -$23.6K | 0.28% | 92 |
|
|
2023
Q1 | $769K | Buy |
4,825
+226
| +5% | +$36K | 0.38% | 69 |
|
|
2022
Q4 | $743K | Buy |
4,599
+349
| +8% | +$56.4K | 0.45% | 69 |
|
|
2022
Q3 | $570K | Buy |
4,250
+363
| +9% | +$48.7K | 0.38% | 73 |
|
|
2022
Q2 | $595K | Buy |
3,887
+12
| +0.3% | +$1.84K | 0.49% | 59 |
|
|
2022
Q1 | $628K | Sell |
3,875
-398
| -9% | -$64.5K | 0.45% | 60 |
|
|
2021
Q4 | $579K | Sell |
4,273
-9
| -0.2% | -$1.22K | 0.31% | 85 |
|
|
2021
Q3 | $462K | Buy |
4,282
+357
| +9% | +$38.5K | 0.26% | 98 |
|
|
2021
Q2 | $442K | Buy |
3,925
+149
| +4% | +$16.8K | 0.29% | 94 |
|
|
2021
Q1 | $409K | Buy |
3,776
+15
| +0.4% | +$1.63K | 0.43% | 59 |
|
|
2020
Q4 | $403K | Sell |
3,761
-159
| -4% | -$17K | 0.52% | 41 |
|
|
2020
Q3 | $343K | Buy |
3,920
+15
| +0.4% | +$1.31K | 0.5% | 47 |
|
|
2020
Q2 | $383K | Buy |
3,905
+188
| +5% | +$18.4K | 0.57% | 34 |
|
|
2020
Q1 | $283K | Sell |
3,717
-71
| -2% | -$5.41K | 0.46% | 48 |
|
|
2019
Q4 | $335K | Buy |
+3,788
| New | +$335K | 0.3% | 57 |
|